Transcriptomic Profiling of Urine Extracellular Vesicles Reveals Alterations of CDH3 in Prostate Cancer

Extracellular vesicles (EV) are emerging structures with promising properties for intercellular communication. In addition, the characterization of EV in biofluids is an attractive source of non-invasive diagnostic, prognostic and predictive biomarkers. Here we show that urinary EV (uEV) from prostate cancer (PCa) patients exhibit genuine and differential physical and biological properties compared to benign prostate hyperplasia (BPH). Importantly, transcriptomics characterization of uEVs led us to define the decreased abundance of Cadherin 3, type 1 (CDH3) transcript in uEV from PCa patients. Tissue and cell line analysis strongly suggested that the status of CDH3 in uEVs is a distal reflection of changes in the expression of this cadherin in the prostate tumor. CDH3 was negatively regulated at the genomic, transcriptional, and epigenetic level in PCa. Our results reveal that uEVs could represent a non-invasive tool to inform about the molecular alterations in PCa.

Citing Articles

Applications of Urinary Extracellular Vesicles in the Diagnosis and Active Surveillance of Prostate Cancer.

Smith S, Brewer D, Hurst R, Cooper C Cancers (Basel). 2024; 16(9).

PMID: 38730670 PMC: 11083542. DOI: 10.3390/cancers16091717.

The Current Progress and Future Options of Multiple Therapy and Potential Biomarkers for Muscle-Invasive Bladder Cancer.

Shi Y, Mathis B, He Y, Yang X Biomedicines. 2023; 11(2).

PMID: 36831075 PMC: 9953154. DOI: 10.3390/biomedicines11020539.

Emerging role of extracellular vesicles in kidney diseases.

Xiang H, Zhang C, Xiong J Front Pharmacol. 2022; 13:985030.

PMID: 36172178 PMC: 9510773. DOI: 10.3389/fphar.2022.985030.

Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients.

Mori J, White J, Elhussin I, Duduyemi B, Karanam B, Yates C Front Oncol. 2022; 12:928357.

PMID: 36033462 PMC: 9399459. DOI: 10.3389/fonc.2022.928357.

Label-free optical redox ratio from urinary extracellular vesicles as a screening biomarker for bladder cancer.

Park J, Kamerer R, Marjanovic M, Sorrells J, You S, Barkalifa R Am J Cancer Res. 2022; 12(5):2068-2083.

PMID: 35693090 PMC: 9185616.

References

Duijvesz D, Versluis C, van der Fels C, den Berg M, Leivo J, Peltola M . Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer. Int J Cancer. 2015; 137(12):2869-78. DOI: 10.1002/ijc.29664. View

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

Bauer R, Valletta D, Bauer K, Thasler W, Hartmann A, Muller M . Downregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity. Int J Clin Exp Pathol. 2014; 7(9):6125-32. PMC: 4203231. View

Taylor B, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver B . Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010; 18(1):11-22. PMC: 3198787. DOI: 10.1016/j.ccr.2010.05.026. View

Berglund L, Bjorling E, Oksvold P, Fagerberg L, Asplund A, Szigyarto C . A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteomics. 2008; 7(10):2019-27. DOI: 10.1074/mcp.R800013-MCP200. View

Overbye A, Skotland T, Koehler C, Thiede B, Seierstad T, Berge V . Identification of prostate cancer biomarkers in urinary exosomes. Oncotarget. 2015; 6(30):30357-76. PMC: 4745805. DOI: 10.18632/oncotarget.4851. View

Kim D, Lee J, Kim S, Choi D, Yoon Y, Kim J . EVpedia: a community web portal for extracellular vesicles research. Bioinformatics. 2014; 31(6):933-9. PMC: 4375401. DOI: 10.1093/bioinformatics/btu741. View

Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G . Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012; 18(6):883-91. PMC: 3645291. DOI: 10.1038/nm.2753. View

Gao J, Aksoy B, Dogrusoz U, Dresdner G, Gross B, Sumer S . Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013; 6(269):pl1. PMC: 4160307. DOI: 10.1126/scisignal.2004088. View

10.

Duijvesz D, Luider T, Bangma C, Jenster G . Exosomes as biomarker treasure chests for prostate cancer. Eur Urol. 2011; 59(5):823-31. DOI: 10.1016/j.eururo.2010.12.031. View

11.

Miranda K, Bond D, McKee M, Skog J, Paunescu T, da Silva N . Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 2010; 78(2):191-9. PMC: 4451567. DOI: 10.1038/ki.2010.106. View

12.

Robinson D, Van Allen E, Wu Y, Schultz N, Lonigro R, Mosquera J . Integrative clinical genomics of advanced prostate cancer. Cell. 2015; 161(5):1215-1228. PMC: 4484602. DOI: 10.1016/j.cell.2015.05.001. View

13.

Jarrard D, Paul R, van Bokhoven A, Nguyen S, Bova G, Wheelock M . P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer. Clin Cancer Res. 1998; 3(11):2121-8. View

14.

Cocucci E, Racchetti G, Meldolesi J . Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009; 19(2):43-51. DOI: 10.1016/j.tcb.2008.11.003. View

15.

Hibi K, Kitamura Y, Mizukami H, Goto T, Sakuraba K, Sakata M . Frequent CDH3 demethylation in advanced gastric carcinoma. Anticancer Res. 2009; 29(10):3945-7. View

16.

Hoorn E, Pisitkun T, Zietse R, Gross P, Frokiaer J, Wang N . Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology (Carlton). 2005; 10(3):283-90. DOI: 10.1111/j.1440-1797.2005.00387.x. View

17.

Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield X . Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer. 2009; 100(10):1603-7. PMC: 2696767. DOI: 10.1038/sj.bjc.6605058. View

18.

Ponten F, Jirstrom K, Uhlen M . The Human Protein Atlas--a tool for pathology. J Pathol. 2008; 216(4):387-93. DOI: 10.1002/path.2440. View

19.

Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M . Towards a knowledge-based Human Protein Atlas. Nat Biotechnol. 2010; 28(12):1248-50. DOI: 10.1038/nbt1210-1248. View

20.

Mitchell P, Welton J, Staffurth J, Court J, Mason M, Tabi Z . Can urinary exosomes act as treatment response markers in prostate cancer?. J Transl Med. 2009; 7:4. PMC: 2631476. DOI: 10.1186/1479-5876-7-4. View